Lv3
202 积分 2024-03-12 加入
Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
1天前
已完结
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
2天前
已完结
Programmed Anuclear Cell Death Delimits Platelet Life Span
2天前
已完结
Initial testing (stage 1) of the BH3 mimetic ABT‐263 by the pediatric preclinical testing program
2天前
已完结
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-xL from NMR and Parallel Synthesis
2天前
已完结
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
2天前
已完结
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
2天前
已完结
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
2天前
已完结
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
3天前
已完结
Ginkgetin Alleviates Inflammation and Senescence by Targeting STING
3天前
已完结
皖公网安备34019202002308
